BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19307668)

  • 1. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
    Ci W; Polo JM; Cerchietti L; Shaknovich R; Wang L; Yang SN; Ye K; Farinha P; Horsman DE; Gascoyne RD; Elemento O; Melnick A
    Blood; 2009 May; 113(22):5536-48. PubMed ID: 19307668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.
    Bal E; Kumar R; Hadigol M; Holmes AB; Hilton LK; Loh JW; Dreval K; Wong JCH; Vlasevska S; Corinaldesi C; Soni RK; Basso K; Morin RD; Khiabanian H; Pasqualucci L; Dalla-Favera R
    Nature; 2022 Jul; 607(7920):808-815. PubMed ID: 35794478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
    Valls E; Lobry C; Geng H; Wang L; Cardenas M; Rivas M; Cerchietti L; Oh P; Yang SN; Oswald E; Graham CW; Jiang Y; Hatzi K; Agirre X; Perkey E; Li Z; Tam W; Bhatt K; Leonard JP; Zweidler-McKay PA; Maillard I; Elemento O; Ci W; Aifantis I; Melnick A
    Cancer Discov; 2017 May; 7(5):506-521. PubMed ID: 28232365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response.
    Tahara K; Takizawa M; Yamane A; Osaki Y; Ishizaki T; Mitsui T; Yokohama A; Saitoh T; Tsukamoto N; Matsumoto M; Murakami H; Nojima Y; Handa H
    Cancer Sci; 2017 Aug; 108(8):1556-1564. PubMed ID: 28544233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein.
    Lee CH; Melchers M; Wang H; Torrey TA; Slota R; Qi CF; Kim JY; Lugar P; Kong HJ; Farrington L; van der Zouwen B; Zhou JX; Lougaris V; Lipsky PE; Grammer AC; Morse HC
    J Exp Med; 2006 Jan; 203(1):63-72. PubMed ID: 16380510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
    Lai AY; Fatemi M; Dhasarathy A; Malone C; Sobol SE; Geigerman C; Jaye DL; Mav D; Shah R; Li L; Wade PA
    J Exp Med; 2010 Aug; 207(9):1939-50. PubMed ID: 20733034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis.
    Hatzi K; Geng H; Doane AS; Meydan C; LaRiviere R; Cardenas M; Duy C; Shen H; Vidal MNC; Baslan T; Mohammad HP; Kruger RG; Shaknovich R; Haberman AM; Inghirami G; Lowe SW; Melnick AM
    Nat Immunol; 2019 Jan; 20(1):86-96. PubMed ID: 30538335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 downregulates transcription factor BCL6 to promote memory B cell selection in germinal centers.
    Shehata L; Thouvenel CD; Hondowicz BD; Pew LA; Pritchard GH; Rawlings DJ; Choi J; Pepper M
    Immunity; 2024 Apr; 57(4):843-858.e5. PubMed ID: 38513666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL6 is a context-dependent mediator of the glioblastoma response to irradiation therapy.
    Tribe AKW; Peng L; Teesdale-Spittle PH; McConnell MJ
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):131782. PubMed ID: 38734343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
    Cerchietti LC; Lopes EC; Yang SN; Hatzi K; Bunting KL; Tsikitas LA; Mallik A; Robles AI; Walling J; Varticovski L; Shaknovich R; Bhalla KN; Chiosis G; Melnick A
    Nat Med; 2009 Dec; 15(12):1369-76. PubMed ID: 19966776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pannexin-3 stabilizes the transcription factor Bcl6 in a channel-independent manner to protect against vascular oxidative stress.
    Wolpe AG; Luse MA; Baryiames C; Schug WJ; Wolpe JB; Johnstone SR; Dunaway LS; Juśkiewicz ZJ; Loeb SA; Askew Page HR; Chen YL; Sabapathy V; Pavelec CM; Wakefield B; Cifuentes-Pagano E; Artamonov MV; Somlyo AV; Straub AC; Sharma R; Beier F; Barrett EJ; Leitinger N; Pagano PJ; Sonkusare SK; Redemann S; Columbus L; Penuela S; Isakson BE
    Sci Signal; 2024 Jan; 17(821):eadg2622. PubMed ID: 38289985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasis.
    Ramachandran K; Futtner CR; Sommars MA; Quattrocelli M; Omura Y; Fruzyna E; Wang JC; Waldeck NJ; Senagolage MD; Telles CG; Demonbreun AR; Prendergast E; Lai N; Arango D; Bederman IR; McNally EM; Barish GD
    Nat Metab; 2024 Feb; 6(2):304-322. PubMed ID: 38337096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.
    Hatzi K; Jiang Y; Huang C; Garrett-Bakelman F; Gearhart MD; Giannopoulou EG; Zumbo P; Kirouac K; Bhaskara S; Polo JM; Kormaksson M; MacKerell AD; Xue F; Mason CE; Hiebert SW; Prive GG; Cerchietti L; Bardwell VJ; Elemento O; Melnick A
    Cell Rep; 2013 Aug; 4(3):578-88. PubMed ID: 23911289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.
    Hatzi K; Melnick A
    Trends Mol Med; 2014 Jun; 20(6):343-52. PubMed ID: 24698494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.
    Basso K; Saito M; Sumazin P; Margolin AA; Wang K; Lim WK; Kitagawa Y; Schneider C; Alvarez MJ; Califano A; Dalla-Favera R
    Blood; 2010 Feb; 115(5):975-84. PubMed ID: 19965633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry.
    Dominguez-Sola D; Victora GD; Ying CY; Phan RT; Saito M; Nussenzweig MC; Dalla-Favera R
    Nat Immunol; 2012 Nov; 13(11):1083-91. PubMed ID: 23001145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation.
    Huang C; Geng H; Boss I; Wang L; Melnick A
    Blood; 2014 Feb; 123(7):1012-20. PubMed ID: 24277074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of BCL6 in normal and transformed germinal center B cells.
    Basso K; Dalla-Favera R
    Immunol Rev; 2012 May; 247(1):172-83. PubMed ID: 22500840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
    Basso K; Dalla-Favera R
    Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.